<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704753</url>
  </required_header>
  <id_info>
    <org_study_id>R18011M</org_study_id>
    <nct_id>NCT03704753</nct_id>
  </id_info>
  <brief_title>New Truncal Nerve Blocks for Thoracoscopic Surgery and Open Heart Surgery.</brief_title>
  <official_title>New Truncal Nerve Blocks for Thoracoscopic Surgery and Open Heart Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is divided to two sub-studies. First sub-study evaluates if Serratus Anterior
      Plane block (SAPB) reduces opioid consumption after thoracoscopic surgery. Secondly
      continuous SAPB is compared to continuous intercostal blockade. Second sub-study evaluates if
      Subpectoral Interfascial Plane block (SIP) reduces opioid consumption after medial
      sternotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serratus anterior plane block (SAPB) - sub-study

      In this sub-study 120 patients will be randomly assigned to one of four groups:

      SAPB group A 30ml of Ropivacaine 7,5mg/ml is injected above m. serratus anterior after
      thoracoscopic lung surgery. Injection is done under ultrasound guidance.

      SAPB group B 30ml of Sodiumchloride 0.9 is injected above m. serratus anterior after
      thoracoscopic lung surgery. Injection is done under ultrasound guidance.

      SAPB group C 30ml of Ropivacaine 7,5mg/m is injected above m. serratus anterior after
      thoracoscopic lung surgery. Also a multi-holed catheter is left in place. Through catheter
      20ml Ropivacaine 2mg/ml is injected every 12 hours after surgery.

      SAPB group D A multi-holed catheter is placed in single intercostal space under thoracoscopic
      visualization. 20ml of Ropivacaine 7,5mg/ml is injected after application of the catheter,
      also a continuous infusion of ropivacaine 2mg/ml is started. Rate of the infusion is
      determined by patients weight.

      Subpectoral Interfascial Plane block (SIP) - sub-study

      In this sub-study 80 patients will be randomly assigned to one of two groups:

      SIP group A 20ml of ropivacaine 7,5mg/ml is injected under both pectoralis major muscles
      before medial sternotomy. Injection is done under ultrasound guidance.

      SIP group B 20ml of sodiumchloride 0.9 is injected under both pectoralis major muscles before
      medial sternotomy. Injection is done under ultrasound guidance.

      Every patients postoperative pain is treated with intravenous ocycodone PCA-pump.

      The investigators will evaluate post operative pain based on the Numeric rating Scale, 24
      hours oxycodone consumption. The investigators will also evaluate post operative chronic pain
      using three questionnaires: EQ5D, STAIT-TRAIT and Pain Detect. In SAPB sub-study the
      questionnaires are done three weeks and 6 months post. operatively. In SIP sub-study the
      questionnaires are done 6 months and 12 months post.operatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2019</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised and double blinded.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>24 postoperative hours</time_frame>
    <description>Oxycodone</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>SAPB group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SAPB single injection. 30ml of Ropivacaine 7,5mg/ml is injected above m. serratus anterior after thoracoscopic lung surgery. Infection is done under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAPB group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>SAPB single injection (placebo). 30ml of SodiumChloride 0.9 is injected above m. serratus anterior after thoracoscopic lung surgery. Infection is done under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAPB group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SAPB single injection and catheter. 30ml of Ropivacaine 7,5mg/ml is injected above m. serratus anterior after thoracoscopic lung surgery and a multi-holed catheter is left in place. 20ml of Ropivacaine 2mg/ml is injected every 12h through catheter postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAPB group D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continious intercostal catheter. 20ml of Ropivacaine 7,5mg/ml is injected through intercostal catheter, which i placed under thoracoscopic visualization. After single injection a continuous infusion of Ropivacaine 2mg/ml is started (weight dependent daily dosage).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIP group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SIP single injection 20ml of Ropivacaine 7,5mg/ml is injected under pectoralis major muscle on both sides of sternum. Injection is done under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIP group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>SIP single injection (placebo) 20ml of SodiumChloride 0.9 is injected under pectoralis major muscle on both sides of sternum. Injection is done under ultrasound guidance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Serratus anterior plane block for thoracic surgery patients and subpectoral interfascial nerve block for open heart surgery patients</description>
    <arm_group_label>SAPB group A</arm_group_label>
    <arm_group_label>SAPB group C</arm_group_label>
    <arm_group_label>SAPB group D</arm_group_label>
    <arm_group_label>SIP group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium chloride 0.9%</intervention_name>
    <description>Serratus anterior plane block for thoracic surgery patients and subpectoral interfascial nerve block for open heart surgery patients (placebo).</description>
    <arm_group_label>SAPB group B</arm_group_label>
    <arm_group_label>SIP group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective thoracoskopic lung surgery or elective open heart valve surgery

        Exclusion Criteria:

          -  DM1 with complications, lack of co-operation, refusal, chronic pain, chronic intake of
             opioids or use of SNRI or tricyclic antidepressants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antti J Kalli, MD</last_name>
    <phone>0500723498</phone>
    <phone_ext>+358</phone_ext>
    <email>antti.kalli@sydansairaala.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kati M Järvelä, MD, PhD</last_name>
    <phone>31164869</phone>
    <phone_ext>+3583</phone_ext>
    <email>kati.jarvela@sydansairaala.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere Heart Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timo Porkkala, Phd</last_name>
      <phone>03311664887</phone>
      <phone_ext>+358</phone_ext>
      <email>timo.porkkala@sydansairaala.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 10, 2018</study_first_submitted>
  <study_first_submitted_qc>October 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>January 25, 2019</last_update_submitted>
  <last_update_submitted_qc>January 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Thoracic Surgery</keyword>
  <keyword>Nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

